Reply to Jon Griffin. TIME for a Change? Multimarker Assessment of the Tumour Immune Microenvironment and Metastatic Site Biopsy to Improve Immunotherapy Response Prediction in Muscle-invasive Bladder Cancer. Eur Urol. 2023;43:143-4
Eur Urol. 2023 Apr;83(4):e115-e116.
doi: 10.1016/j.eururo.2023.01.013.
Epub 2023 Jan 24.
1 Department of Urology and Pediatric Urology, University Medical Center Bonn, Bonn, Germany; Institute of Experimental Oncology, University Medical Center Bonn, Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf, Bonn, Germany; BRIDGE Consortium e.V, Germany.
2 Institute of Experimental Oncology, University Medical Center Bonn, Bonn, Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf, Bonn, Germany.
3 BRIDGE Consortium e.V, Germany; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research, Munich, Germany. Electronic address: markus.eckstein@uk-erlangen.de.